{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:15:13Z","timestamp":1790111713640,"version":"4.0.1"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,5,29]],"date-time":"2015-05-29T00:00:00Z","timestamp":1432857600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s40272-015-0135-3","type":"journal-article","created":{"date-parts":[[2015,5,28]],"date-time":"2015-05-28T10:10:44Z","timestamp":1432807844000},"page":"303-313","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Current Management of Pediatric Vitiligo"],"prefix":"10.1007","volume":"17","author":[{"given":"Freya","family":"Van Driessche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanette","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,29]]},"reference":[{"key":"135_CR1","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1089\/thy.2010.1643","volume":"20","author":"RA Spritz","year":"2010","unstructured":"Spritz RA. Shared genetic relationships underlying generalized vitiligo and autoimmune thyroid disease. Thyroid. 2010;20:745\u201354.","journal-title":"Thyroid."},{"issue":"5 Pt 1","key":"135_CR2","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S0190-9622(87)70119-4","volume":"16","author":"RM Halder","year":"1987","unstructured":"Halder RM, Grimes PE, Cowan CA, Enterline JA, Chakrabarti SG, Kenney JA Jr. Childhood vitiligo. J Am Acad of Dermatol. 1987;16(5 Pt 1):948\u201354.","journal-title":"J Am Acad of Dermatol."},{"key":"135_CR3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s13671-014-0098-6","volume":"4","author":"NB Silverberg","year":"2015","unstructured":"Silverberg NB. The Epidemiology of vitiligo. Curr Derm Rep. 2015;4:36\u201343.","journal-title":"Curr Derm Rep."},{"key":"135_CR4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/pde.12226","volume":"31","author":"JI Silverberg","year":"2014","unstructured":"Silverberg JI, Silverberg NB. Quality of life impairment in children and adolescents with vitiligo. Pediatr Dermatol. 2014;31:309\u201318.","journal-title":"Pediatr Dermatol."},{"issue":"1","key":"135_CR5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2133.2012.11197.x","volume":"168","author":"A Taieb","year":"2013","unstructured":"Taieb A, Alomar A, B\u00f6hm M, Dell\u2019anna ML, De Pase A, Eleftheriadou V, Ezzedine K, Gauthier Y, Gawkrodger DJ, Jouary T, Leone G, Moretti S, Nieuweboer-Krobotova L, Olsson MJ, Parsad D, Passeron T, Tanew A, van der Veen W, van Geel N, Whitton M, Wolkerstorfer A, Picardo M, VitiligoEuropean Task Force (VETF), European Academy of Dermatology and Venereology (EADV), Union Europe\u00b4enne des Me\u00b4decins Spe\u00b4cialistes (UEMS). Guidelines for the management of vitiligo: the European Dermatology Forum consensus. Br J Dermatol. 2013;168(1):5\u201319.","journal-title":"Br J Dermatol."},{"issue":"5","key":"135_CR6","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1365-2133.2008.08881.x","volume":"159","author":"DJ Gawkrodger","year":"2008","unstructured":"Gawkrodger DJ, Ormerod AD, Shaw L, Mauri-Sole I, Whitton ME, Watts MJ, Anstey AV, Ingham J, Young K, Therapy Guidelines and Audit Subcommittee, British Association of Dermatologists, Clinical Standards Department, Royal College of Physicians of London, Cochrane Skin Group, Vitiligo Society. Guideline for the diagnosis and management of vitiligo. Br J Dermatol. 2008;159(5):1051\u201376.","journal-title":"Br J Dermatol."},{"issue":"4","key":"135_CR7","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jaad.2008.06.023","volume":"59","author":"ME Whitton","year":"2008","unstructured":"Whitton ME, Ashcroft DM, Gonz\u00e1lez U. Therapeutic interventions for vitiligo. J Am Acad Dermatol. 2008;59(4):713\u20137.","journal-title":"J Am Acad Dermatol."},{"issue":"3","key":"135_CR8","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/bjd.12669","volume":"170","author":"F Meredith","year":"2014","unstructured":"Meredith F, Abbott R. Vitiligo: an\u00a0evidence-based\u00a0update. Report of the 13th\u00a0Evidence\u00a0Based\u00a0Update Meeting, 23 May 2013, Loughborough, UK. Br J Dermatol. 2014;170(3):565\u201370.","journal-title":"Br J Dermatol."},{"issue":"5","key":"135_CR9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/1346-8138.12099","volume":"40","author":"N Oiso","year":"2013","unstructured":"Oiso N, Suzuki T, Wataya-Kaneda M, Tanemura A, Tanioka M, Fujimoto T, Fukai K, Kawakami T, Tsukamoto K, Yamaguchi Y, Sano S, Mitsuhashi Y, Nishigori C, Morita A, Nakagawa H, Mizoguchi M, Katayama I. Guidelines for the diagnosis and treatment of\u00a0vitiligo\u00a0in Japan. J Dermatol. 2013;40(5):344\u201354.","journal-title":"J Dermatol."},{"key":"135_CR10","doi-asserted-by":"crossref","unstructured":"Lotti T, D\u2019Erme AM. Vitiligo as a systemic disease. Clin Dermatol. 2014;32(3):430\u20134.","DOI":"10.1016\/j.clindermatol.2013.11.011"},{"key":"135_CR11","doi-asserted-by":"crossref","unstructured":"Pietrzak A, Bartosi\u0144ska J, Hercogov\u00e1 J, Lotti TM, Chodorowska G. Metabolic syndrome in vitiligo. Dermatol Ther. 2012;25(Suppl 1):S41\u20133.","DOI":"10.1111\/dth.12012"},{"issue":"1","key":"135_CR12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1755-148X.2011.00939.x","volume":"25","author":"A Ta\u00efeb","year":"2012","unstructured":"Ta\u00efeb A. Vitiligo as an inflammatory skin disorder: a therapeutic perspective. Pigment Cell Melanoma Res. 2012;25(1):9\u201313.","journal-title":"Pigment Cell Melanoma Res."},{"key":"135_CR13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.pcl.2013.11.008","volume":"61","author":"NB Silverberg","year":"2014","unstructured":"Silverberg NB. Pediatric vitiligo. Pediatr Clin N Am. 2014;61:347\u201366.","journal-title":"Pediatr Clin N Am."},{"key":"135_CR14","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.clindermatol.2014.02.006","volume":"32","author":"NB Silverberg","year":"2014","unstructured":"Silverberg NB. Recent advances in childhood vitiligo. Clin Dermatol. 2014;32:524\u201330.","journal-title":"Clin Dermatol."},{"key":"135_CR15","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1755-148X.2012.00997.x","volume":"25","author":"K Ezzedine","year":"2012","unstructured":"Ezzedine K, Lim HW, Suzuki T, Katayama I, Hamzavi I, Lan CC, et al. Revised classification\/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Pigm Cell Melanoma Res. 2012;25:E1\u201313.","journal-title":"Pigm Cell Melanoma Res."},{"issue":"2","key":"135_CR16","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jaad.2005.03.032","volume":"53","author":"T Kakourou","year":"2005","unstructured":"Kakourou T, Kanaka-Gantenbein C, Papadopoulou A, Kaloumenou E, Chrousos GP. Increased prevalence of chronic autoimmune (Hashimoto\u2019s) thyroiditis in children and adolescents with vitiligo. J Am Acad Dermatol. 2005;53(2):220\u20133.","journal-title":"J Am Acad Dermatol."},{"issue":"6","key":"135_CR17","first-page":"463","volume":"81","author":"OE Pagovich","year":"2008","unstructured":"Pagovich OE, Silverberg JI, Freilich E, Silverberg NB. Thyroid abnormalities in pediatric patients with vitiligo in New York City. Cutis. 2008;81(6):463\u20136.","journal-title":"Cutis."},{"issue":"6","key":"135_CR18","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.4103\/2230-8210.122636","volume":"17","author":"FS Afsar","year":"2013","unstructured":"Afsar FS, Isleten F. Prevalence of thyroid function test abnormalities and thyroid autoantibodies in children with vitiligo. Indian J Endocrinol Metab. 2013;17(6):1096\u20139.","journal-title":"Indian J Endocrinol Metab."},{"issue":"4","key":"135_CR19","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/bjd.12166","volume":"168","author":"A Gey","year":"2013","unstructured":"Gey A, Diallo A, Seneschal J, L\u00e9aut\u00e9-Labr\u00e8ze C, Boralevi F, Jouary T, Taieb A, Ezzedine K. Autoimmune thyroid disease in vitiligo: multivariate analysis indicates intricate pathomechanisms. Br J Dermatol. 2013;168(4):756\u201361.","journal-title":"Br J Dermatol."},{"issue":"6","key":"135_CR20","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jaad.2009.11.024","volume":"62","author":"JI Silverberg","year":"2010","unstructured":"Silverberg JI, Silverberg AI, Malka E, Silverberg NB. A pilot study assessing the role of 25 hydroxy vitamin D levels in patients with vitiligo vulgaris. J Am Acad Dermatol. 2010;62(6):937\u201341.","journal-title":"J Am Acad Dermatol."},{"issue":"3","key":"135_CR21","first-page":"154","volume":"41","author":"V Ertekin","year":"2009","unstructured":"Ertekin V, Selimoglu MA, Altinkaynak S. Celiac disease in childhood: evaluation of 140 patients. Eurasian J Med. 2009;41(3):154\u20137.","journal-title":"Eurasian J Med."},{"issue":"4","key":"135_CR22","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4103\/0019-5154.135485","volume":"59","author":"Y Yang","year":"2014","unstructured":"Yang Y, Huang G, Yan X, Qing Z. Clinical analysis of thyroglobulin antibody and thyroid peroxidase antibody and their association with\u00a0vitiligo. Indian J Dermatol. 2014;59(4):357\u201360. doi: 10.4103\/0019-5154.135485 .","journal-title":"Indian J Dermatol."},{"key":"135_CR23","doi-asserted-by":"crossref","unstructured":"Linthorst Homan MW, de Korte J, Grootenhuis MA, Bos JD, Sprangers MA, van der Veen JP. Impact of childhood vitiligo on adult life. Br J Dermatol. 2008;159:915\u201320. 8.","DOI":"10.1111\/j.1365-2133.2008.08788.x"},{"key":"135_CR24","unstructured":"Ongenae K, Van Geel N, De Schepper S, Vander Haeghen Y, Naeyaert JM. Management of vitiligo patients and attitude of dermatologists towards vitiligo. Eur J Dermatol. 2004;14:177\u201381."},{"key":"135_CR25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/phpp.12029","volume":"29","author":"JH Park","year":"2013","unstructured":"Park JH, Park SW, Lee DY, Lee JH, Yang JM. The effectiveness of early treatment in segmental vitiligo: retrospective study according to disease duration. Photodermatol Photoimmunol Photomed. 2013;29:103\u20135.","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"135_CR26","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1067\/mjd.2002.120576","volume":"46","author":"SE Cockayne","year":"2002","unstructured":"Cockayne SE, Messenger AG, Gawkrodger DJ. Vitiligo treated with topical corticosteroids: children with head and neck involvement respond well. J Am Acad Dermatol. 2002;46:964\u20135.","journal-title":"J Am Acad Dermatol."},{"issue":"3","key":"135_CR27","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1034\/j.1600-0749.2003.00032.x","volume":"16","author":"A Alkhateeb","year":"2003","unstructured":"Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res. 2003;16(3):208\u201314.","journal-title":"Pigment Cell Res."},{"key":"135_CR28","first-page":"370","volume":"77","author":"NB Silverberg","year":"2006","unstructured":"Silverberg NB, Travis L. Childhood vitiligo. Cutis. 2006;77:370\u20135.","journal-title":"Cutis."},{"key":"135_CR29","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jaad.2004.05.036","volume":"51","author":"NB Silverberg","year":"2004","unstructured":"Silverberg NB, Lin P, Travis L, Farley-Li J, Mancini AJ, Wagner AM, et al. Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases. J Am Acad Dermatol. 2004;51:760\u20136.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"135_CR30","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/phpp.12029","volume":"29","author":"JH Park","year":"2013","unstructured":"Park JH, Park SW, Lee DY, Lee JH, Yang JM. The effectiveness of early treatment in\u00a0segmental\u00a0vitiligo: retrospective study according to disease duration. Photodermatol Photoimmunol Photomed. 2013;29(2):103\u20135.","journal-title":"Photodermatol Photoimmunol Photomed."},{"key":"135_CR31","doi-asserted-by":"crossref","unstructured":"West DP, Worobec S, Solomon LM. Pharmacology and toxicology of infant skin. J Invest Dermatol. 1981;76:147\u201350.","DOI":"10.1111\/1523-1747.ep12525553"},{"key":"135_CR32","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3928\/00904481-20090522-01","volume":"38","author":"AL Isenstein","year":"2009","unstructured":"Isenstein AL, Morrell DS, Burkhart CN. Vitiligo: treatment approach in children. Ped Annals. 2009;38:339\u201344.","journal-title":"Ped Annals"},{"key":"135_CR33","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jaad.2006.08.017","volume":"56","author":"J Kwinter","year":"2007","unstructured":"Kwinter J, Pelletier J, Khambalia A, Pope E. High-potency steroid use in children with vitiligo: a retrospective study. J Am Acad Dermatol. 2007;56:236\u201341.","journal-title":"J Am Acad Dermatol."},{"key":"135_CR34","doi-asserted-by":"crossref","unstructured":"Ho N, Pope E, Weinstein M, Greenberg S, Webster C, Krafchik BR. A double-blind, randomized, placebo-controlled trial of topical tacrolimus 0.1\u00a0% vs. clobetasol propionate 0.05\u00a0% in childhood vitiligo. Br J Dermatol. 2011;165:626\u201332.","DOI":"10.1111\/j.1365-2133.2011.10351.x"},{"key":"135_CR35","doi-asserted-by":"crossref","unstructured":"Lepe V, Moncada B, Castanedo-Cazares JP, Torres-Alvarez MB, Ortiz CA, Torres-Rubalcava AB. A double-blind randomized trial of 0.1\u00a0% tacrolimus vs 0.05\u00a0% clobetasol for the treatment of childhood vitiligo. Arch Dermatol. 2003;139:581\u20135.","DOI":"10.1001\/archderm.139.5.581"},{"key":"135_CR36","unstructured":"Coskun B, Saral Y, Turgut D. Topical 0.05\u00a0% clobetasol propionate versus 1\u00a0% pimecrolimus ointment in vitiligo. Eur J Dermatol. 2005;15:88\u201391."},{"key":"135_CR37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-5945-11-7","volume":"11","author":"R Yaghoobi","year":"2011","unstructured":"Yaghoobi R, Omidian M, Bagherani N. Original article title: \u201cComparison of therapeutic efficacy of topical corticosteroid and oral zinc sulfate-topical corticosteroid combination in the treatment of vitiligo patients: a clinical trial\u201d. BMC Dermatol. 2011;11:7.","journal-title":"BMC Dermatol"},{"key":"135_CR38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1525-1470.2012.01808.x","volume":"30","author":"R Kojima","year":"2013","unstructured":"Kojima R, Fujiwara T, Matsuda A, Narita M, Matsubara O, Nonoyama S, et al. Factors associated with steroid phobia in caregivers of children with atopic dermatitis. Pediatr dermatol. 2013;30:29\u201335.","journal-title":"Pediatr dermatol."},{"key":"135_CR39","doi-asserted-by":"crossref","first-page":"465","DOI":"10.4103\/0019-5154.139876","volume":"59","author":"A Ghosh","year":"2014","unstructured":"Ghosh A, Sengupta S, Coondoo A, Jana AK. Topical corticosteroid addiction and phobia. Ind J dermatol. 2014;59:465\u20138.","journal-title":"Ind J dermatol."},{"key":"135_CR40","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/j.1346-8138.2010.01124.x","volume":"38","author":"D Juan","year":"2011","unstructured":"Juan D, Qianxi X, Zhou C, Jianzhong Z. Clinical efficacy and safety of tacrolimus ointment in patients with vitiligo. J Dermatol. 2011;38:1092\u20134.","journal-title":"J Dermatol."},{"key":"135_CR41","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1346-8138.2010.01067.x","volume":"38","author":"M Udompataikul","year":"2011","unstructured":"Udompataikul M, Boonsupthip P, Siriwattanagate R. Effectiveness of 0.1\u00a0% topical tacrolimus in adult and children patients with vitiligo. J Dermatol. 2011;38:536\u201340.","journal-title":"J Dermatol."},{"key":"135_CR42","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/archderm.139.5.571","volume":"139","author":"LB Travis","year":"2003","unstructured":"Travis LB, Weinberg JM, Silverberg NB. Successful treatment of vitiligo with 0.1\u00a0% tacrolimus ointment. Arch Dermatol. 2003;139:571\u20134.","journal-title":"Arch Dermatol."},{"key":"135_CR43","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jaad.2004.05.036","volume":"51","author":"NB Silverberg","year":"2004","unstructured":"Silverberg NB, Lin P, Travis L, Farley-Li J, Mancini AJ, Wagner AM, et al. Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases. J Am Acad Dermatol. 2004;51:760\u20136.","journal-title":"J Am Acad Dermatol"},{"key":"135_CR44","first-page":"507","volume":"10","author":"JI Silverberg","year":"2011","unstructured":"Silverberg JI, Silverberg NB. Topical tacrolimus is more effective for treatment of vitiligo in patients of skin of color. J Drug Dermatol. 2011;10:507\u201310.","journal-title":"J Drug Dermatol."},{"key":"135_CR45","first-page":"560","volume":"144","author":"M Mikhail","year":"2008","unstructured":"Mikhail M, Wolchok J, Goldberg SM, Dunkel IJ, Roses DF, Silverberg NB. Rapid enlargement of a malignant melanoma in a child with vitiligo vulgaris after application of topical tacrolimus. Arch Dermatol. 2008;144:560\u20131.","journal-title":"Arch Dermatol."},{"key":"135_CR46","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.0022-202X.2005.23644.x","volume":"124","author":"J Harper","year":"2005","unstructured":"Harper J, Smith C, Rubins A, Green A, Jackson K, Zigure S, et al. A multicenter study of the pharmacokinetics of tacrolimus ointment after first and repeated application to children with atopic dermatitis. J Invest Dermatol. 2005;124:695\u20139.","journal-title":"J Invest Dermatol"},{"key":"135_CR47","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1001\/archderm.139.9.1184","volume":"139","author":"RR Patel","year":"2003","unstructured":"Patel RR, Vander Straten MR, Korman NJ. The safety and efficacy of tacrolimus therapy in patients younger than 2 years with atopic dermatitis. Arch Dermatol. 2003;139:1184\u20136.","journal-title":"Arch Dermatol."},{"issue":"Suppl 1","key":"135_CR48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000102116","volume":"215","author":"LF Eichenfield","year":"2007","unstructured":"Eichenfield LF, Thaci D, de Prost Y, Puig L, Paul C. Clinical management of atopic eczema with pimecrolimus cream 1\u00a0% (Elidel) in paediatric patients. Dermatol. 2007;215(Suppl 1):3\u201317.","journal-title":"Dermatol."},{"key":"135_CR49","doi-asserted-by":"crossref","unstructured":"Radakovic S, Breier-Maly J, Konschitzky R, Kittler H, Sator P, Hoenigsmann H, et al. Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial. JEADV. 2009;23:951\u20133.","DOI":"10.1111\/j.1468-3083.2009.03138.x"},{"key":"135_CR50","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1525-1470.2009.00926.x","volume":"26","author":"S Farajzadeh","year":"2009","unstructured":"Farajzadeh S, Daraei Z, Esfandiarpour I, Hosseini SH. The efficacy of pimecrolimus 1\u00a0% cream combined with microdermabrasion in the treatment of nonsegmental childhood vitiligo: a randomized placebo-controlled study. Pediatr Dermatol. 2009;26:286\u201391.","journal-title":"Pediatr Dermatol."},{"key":"135_CR51","first-page":"5","volume":"14","author":"S Berti","year":"2009","unstructured":"Berti S, Buggiani G, Lotti T. Use of tacrolimus ointment in vitiligo alone or in combination therapy. Skin Ther Lett. 2009;14:5\u20137.","journal-title":"Skin Ther Lett."},{"key":"135_CR52","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/09546630802155057","volume":"20","author":"I Esfandiarpour","year":"2009","unstructured":"Esfandiarpour I, Ekhlasi A, Farajzadeh S, Shamsadini S. The efficacy of pimecrolimus 1\u00a0% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial. J Dermatol Treat. 2009;20:14\u20138.","journal-title":"J Dermatol Treat."},{"key":"135_CR53","doi-asserted-by":"crossref","unstructured":"Margolis DJ, Abuabara K, Hoffstad OJ, Wan J, Raimondo D, Bilker WB. Association between malignancy and topical use of pimecrolimus. JAMA Dermatol. 2015. doi: 10.1001\/jamadermatol.2014.4305 .","DOI":"10.1001\/jamadermatol.2014.4305"},{"key":"135_CR54","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s40257-013-0020-1","volume":"14","author":"EC Siegfried","year":"2013","unstructured":"Siegfried EC, Jaworski JC, Hebert AA. Topical calcineurin inhibitors and lymphoma risk: evidence update with implications for daily practice. Am J Clin Dermatol. 2013;14:163\u201378.","journal-title":"Am J Clin Dermatol"},{"key":"135_CR55","first-page":"e52","volume":"11","author":"C Xing","year":"2012","unstructured":"Xing C, Xu A. The effect of combined calcipotriol and betamethasone dipropionate ointment in the treatment of vitiligo: an open, uncontrolled trial. J Drugs Dermatol JDD. 2012;11:e52\u20134.","journal-title":"J Drugs Dermatol JDD."},{"key":"135_CR56","first-page":"256","volume":"88","author":"MD Newman","year":"2011","unstructured":"Newman MD, Silverberg NB. Once-daily application of calcipotriene 0.005\u00a0%-betamethasone dipropionate 0.064\u00a0% ointment for repigmentation of facial vitiligo. Cutis. 2011;88:256\u20139.","journal-title":"Cutis."},{"key":"135_CR57","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.0736-8046.2004.21418.x","volume":"21","author":"LB Travis","year":"2004","unstructured":"Travis LB, Silverberg NB. Calcipotriene and corticosteroid combination therapy for vitiligo. Pediatr Dermatol. 2004;21:495\u20138.","journal-title":"Pediatr Dermatol."},{"key":"135_CR58","doi-asserted-by":"crossref","unstructured":"De-Regil LM, Palacios C, Ansary A, Kulier R, Pena-Rosas JP. Vitamin D supplementation for women during pregnancy. Cochr Rev. 2012;2:CD008873.","DOI":"10.1002\/14651858.CD008873.pub2"},{"key":"135_CR59","doi-asserted-by":"crossref","unstructured":"Weisberg P, Scanlon KS, Li R, Cogswell ME. Vitamin D dose requirements for fracture prevention. Nutritional rickets among children in the United States: review of cases reported between 1986 and 2003. Am J Clin Nutr. 2004;80(6 Suppl):1697S\u2013705S.","DOI":"10.1093\/ajcn\/80.6.1697S"},{"issue":"14","key":"135_CR60","first-page":"1368","volume":"367","author":"CJ Rosen","year":"2012","unstructured":"Rosen CJ, Mayne ST. IOM Committee on dietary reference intakes for\u00a0vitamin D\u00a0and calcium. N Engl J Med. 2012;367(14):1368.","journal-title":"N Engl J Med."},{"key":"135_CR61","unstructured":"http:\/\/www.iom.edu\/Reports\/2010\/Dietary-Reference-Intakes-for-Calcium-and-Vitamin-D.aspx . Accessed 8 May 2015."},{"key":"135_CR62","doi-asserted-by":"crossref","unstructured":"Finamor DC, Sinigaglia-Coimbra R, Neves LC, Gutierrez M, Silva JJ, Torres LD, Surano F, Neto DJ, Novo NF, Juliano Y, Lopes AC, Coimbra CG. A pilot study assessing the effect of prolonged administration of high daily doses of vitamin D on the clinical course of vitiligo and psoriasis. Dermatoendocrinol. 2013;5(1):222\u201334. doi: 10.4161\/derm.24808 .","DOI":"10.4161\/derm.24808"},{"issue":"3","key":"135_CR63","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3349\/ymj.1999.40.3.195","volume":"40","author":"SM Kim","year":"1999","unstructured":"Kim SM, Kim YK, Hann SK. Serum levels of folic acid and vitamin B12 in Korean patients with vitiligo. Yonsei Med J. 1999;40(3):195\u20138.","journal-title":"Yonsei Med J."},{"issue":"1","key":"135_CR64","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/00015550410021565","volume":"85","author":"HH Park","year":"2005","unstructured":"Park HH, Lee MH. Serum levels of vitamin B12 and folate in Korean patients with vitiligo. Acta Derm Venereol. 2005;85(1):66\u20137.","journal-title":"Acta Derm Venereol."},{"key":"135_CR65","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejogrb.2012.06.020","volume":"164","author":"N Hovdenak","year":"2012","unstructured":"Hovdenak N, Haram K. Influence of mineral and vitamin supplements on pregnancy outcome. Eur J Obstet Gynecol Reprod Biol. 2012;164:127\u201332.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"17","key":"135_CR66","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.3109\/14767058.2013.879702","volume":"27","author":"MS Gadgil","year":"2014","unstructured":"Gadgil MS, Joshi KS, Naik SS, Pandit AN, Otiv SR, Patwardhan BK. Association of homocysteine with global DNA methylation in vegetarian Indian pregnant women and neonatal birth anthropometrics. J Mat Fetal Neon Med. 2014;27(17):1749\u201353.","journal-title":"J Mat Fetal Neon Med"},{"key":"135_CR67","unstructured":"http:\/\/www.nal.usda.gov\/fnic\/DRI\/DRI_Tables\/RDA_AI_vitamins_elements.pdf . Accessed 15 Mar 2015."},{"key":"135_CR68","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1472-6882-11-21","volume":"11","author":"O Szczurko","year":"2011","unstructured":"Szczurko O, Shear N, Taddio A, Boon H. Ginkgo biloba for the treatment of vitilgo vulgaris: an open label pilot clinical trial. BMC Comp Alt Med. 2011;11:21.","journal-title":"BMC Comp Alt Med."},{"key":"135_CR69","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10072-010-0411-5","volume":"32","author":"M Esposito","year":"2011","unstructured":"Esposito M, Carotenuto M. Ginkgolide B complex efficacy for brief prophylaxis of migraine in school-aged children: an open-label study. Neurol Sci. 2011;32:79\u201381.","journal-title":"Neurol Sci."},{"key":"135_CR70","first-page":"e277","volume":"13","author":"JJ Dugoua","year":"2006","unstructured":"Dugoua JJ, Mills E, Perri D, Koren G. Safety and efficacy of ginkgo (Ginkgo biloba) during pregnancy and lactation. Can J Pharmacol. 2006;13:e277\u201384.","journal-title":"Can J Pharmacol."},{"key":"135_CR71","first-page":"117","volume":"20","author":"U Zehra","year":"2010","unstructured":"Zehra U, Tahir M, Lone KP. Ginkgo biloba induced malformations in mice. J CollPhys Surg-Pak. 2010;20:117\u201321.","journal-title":"J CollPhys Surg-Pak."},{"issue":"5","key":"135_CR72","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jaad.2014.07.029","volume":"71","author":"ML Ramien","year":"2014","unstructured":"Ramien ML, Ondrejchak S, Gendron R, Hatami A, McCuaig CC, Powell J, et al. Quality of life in pediatric patients before and after cosmetic camouflage of visible skin conditions. J Amer Acad Dermatol 2014;71(5):935\u201340.","journal-title":"J Amer Acad Dermatol"},{"key":"135_CR73","first-page":"23","volume":"14","author":"S Hsu","year":"2008","unstructured":"Hsu S. Camouflaging vitiligo with dihydroxyacetone. Dermatol Online J. 2008;14:23.","journal-title":"Dermatol Online J"},{"issue":"401","key":"135_CR74","first-page":"e1","volume":"70","author":"JE Murase","year":"2014","unstructured":"Murase JE, Heller MM, Butler DC. Safety of dermatologic medications in pregnancy and lactation: Part I. Pregnancy. J Am Acad Dermatol. 2014;70(401):e1\u201314.","journal-title":"J Am Acad Dermatol."},{"issue":"4","key":"135_CR75","first-page":"327","volume":"63","author":"W Veith","year":"2011","unstructured":"Veith W, Deleo V, Silverberg N. Medical phototherapy in childhood skin diseases. Minerva Pediatr. 2011;63(4):327\u201333.","journal-title":"Minerva Pediatr."},{"key":"135_CR76","unstructured":"Yoshida A, Takagi A, Ikejima A, Takenaka H, Fukai T, Ikeda S. A retrospective study of 231 Japanese vitiligo patients with special reference to phototherapy. Acta Dermatovenerol Croat. 2014;22(1):13\u20138."},{"issue":"2 Pt 1","key":"135_CR77","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0190-9622(00)90133-6","volume":"42","author":"MD Njoo","year":"2000","unstructured":"Njoo MD, Bos JD, Westerhof W. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol. 2000;42(2 Pt 1):245\u201353.","journal-title":"J Am Acad Dermatol."},{"key":"135_CR78","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2230.2005.01837.x","volume":"30","author":"AJ Kanwar","year":"2005","unstructured":"Kanwar AJ, Dogra S. Narrow-band UVB for the treatment of generalized vitiligo in children. Clin Exper Dermatol. 2005;30:332\u20136.","journal-title":"Clin Exper Dermatol."},{"key":"135_CR79","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1525-1470.2010.01159.x","volume":"27","author":"ME Tamesis","year":"2010","unstructured":"Tamesis ME, Morelli JG. Vitiligo treatment in childhood: a state of the art review. Pediatr Dermatol. 2010;27:437\u201345.","journal-title":"Pediatr Dermatol."},{"key":"135_CR80","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1600-0781.2010.00558.x","volume":"27","author":"S Cho","year":"2011","unstructured":"Cho S, Zheng Z, Park YK, Roh MR. The 308-nm excimer laser: a promising device for the treatment of childhood vitiligo. Photodermatol Photoimmunol Photomed. 2011;27:24\u20139.","journal-title":"Photodermatol Photoimmunol Photomed."},{"issue":"1","key":"135_CR81","first-page":"13","volume":"22","author":"A Yoshida","year":"2014","unstructured":"Yoshida A, Takagi A, Ikejima A, Takenaka H, Fukai T, Ikeda S. A retrospective study of 231 Japanese\u00a0vitiligo\u00a0patients with special reference to phototherapy. Acta Dermatovenerol Croat. 2014;22(1):13\u20138.","journal-title":"Acta Dermatovenerol Croat."},{"issue":"6","key":"135_CR82","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jaad.2014.07.050","volume":"71","author":"A Paradisi","year":"2014","unstructured":"Paradisi A, Tabolli S, Didona B, Sobrino L, Russo N, Abeni D. Markedly reduced incidence of melanoma and nonmelanoma skin cancer in a nonconcurrent cohort of 10,040 patients with vitiligo. J Am Acad Dermatol. 2014;71(6):1110\u20136.","journal-title":"J Am Acad Dermatol."},{"key":"135_CR83","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1365-2133.2012.11008.x","volume":"167","author":"KK Park","year":"2012","unstructured":"Park KK, Liao W, Murase JE. A review of monochromatic excimer light in vitiligo. BrJ Dermatol. 2012;167:468\u201378.","journal-title":"BrJ Dermatol."},{"issue":"1","key":"135_CR84","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/jamadermatol.2014.1875","volume":"151","author":"HW Lim","year":"2015","unstructured":"Lim HW, Grimes PE, Agbai O, Hamzavi I, Henderson M, Haddican M, et al. Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: A Randomized Multicenter Trial. JAMA Dermatol. 2015;151(1):42\u201350.","journal-title":"JAMA Dermatol."},{"key":"135_CR85","doi-asserted-by":"crossref","unstructured":"Hui-Lan Y, Xiao-Yan H, Jian-Yong F, Zong-Rong L. Combination of 308-nm\u00a0excimer laser\u00a0with topical pimecrolimus for the treatment of childhood vitiligo. Pediatr Dermatol. 2009;26(3):354\u20136.","DOI":"10.1111\/j.1525-1470.2009.00914.x"},{"issue":"9","key":"135_CR86","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1177\/0009922810363169","volume":"49","author":"N Patel","year":"2010","unstructured":"Patel N, O\u2019Haver J, Hansen RC. Vitiligo therapy in children: a case for considering excimer laser treatment. Clin Pediatr (Phila). 2010;49(9):823\u20139.","journal-title":"Clin Pediatr (Phila)."},{"key":"135_CR87","first-page":"248","volume":"91","author":"C Grau","year":"2013","unstructured":"Grau C, Silverberg NB. Vitiligo patients seeking depigmentation therapy: a case report and guidelines for psychological screening. Cutis. 2013;91:248\u201352.","journal-title":"Cutis."},{"issue":"6","key":"135_CR88","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1468-3083.2011.04147.x","volume":"26","author":"MW Linthorst Homan","year":"2012","unstructured":"Linthorst Homan MW, Spuls PI, Nieuweboer-Krobotova L, de Korte J, Sprangers MA, Bos JD, Wolkerstorfer A, van der Veen JP. A randomized comparison of excimer laser versus narrow-band ultraviolet B phototherapy after punch grafting in stable vitiligo patients. J Eur Acad Dermatol Venereol. 2012;26(6):690\u20135.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"5","key":"135_CR89","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1468-3083.2011.04097.x","volume":"26","author":"L Yao","year":"2012","unstructured":"Yao L, Li SS, Zhong SX, Song Y, Hu DN, Guo JW. Successful treatment of vitiligo on the axilla in a 5-years-old child by cultured-melanocytetransplantation. J Eur Acad Dermatol Venereol. 2012;26(5):658\u201360.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"4","key":"135_CR90","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/dsu.12444","volume":"40","author":"DM Zhang","year":"2014","unstructured":"Zhang DM, Hong WS, Fu LF, Wei XD, Xu AE. A randomized controlled study of the effects of different modalities of narrow-band ultraviolet B therapy on the outcome of cultured autologous melanocytes transplantation in treating vitiligo. Dermatol Surg. 2014;40(4):420\u20136.","journal-title":"Dermatol Surg."}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-015-0135-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40272-015-0135-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-015-0135-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T14:18:18Z","timestamp":1566742698000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40272-015-0135-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,29]]},"references-count":90,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["135"],"URL":"https:\/\/doi.org\/10.1007\/s40272-015-0135-3","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,29]]}}}